Rabigen SAG2


live vaccine against rabies

This medicine is authorised for use in the European Union.


This is a summary of the European public assessment report (EPAR). Its purpose is to explain how the assessment done by the Committee for Medicinal Products for Veterinary Use (CVMP) on the basis of the documentation provided, led to the recommendations on the conditions of use.

This summary cannot replace a face-to-face discussion with your veterinarian. If you need more information about your animal’s medical condition or treatment, contact your veterinarian. If you want more information on the basis of the CVMP recommendations, read the scientific discussion (also part of the EPAR).

This EPAR was last updated on 06/11/2018

Authorisation details

Product details
Rabigen SAG2
Agency product number
Active substance
live attenuated rabies virus, SAG2 strain
International non-proprietary name (INN) or common name
live vaccine against rabies
  • Raccoon dogs (Nyctereutes procyonoides)
  • Red foxes (Vulpes vulpes)
Anatomical therapeutic chemical veterinary (ATCvet) codes
Publication details
Marketing-authorisation holder
Virbac S.A.
Date of issue of marketing authorisation valid throughout the European Union
Contact address

1ère Avenue 2065 M - L.I.D.
06516 Carros Cedex

Product information

06/11/2018 Rabigen SAG2 - EMEA/V/C/000043 - IG/0984

Other EU languages available icon This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.


Product information documents contain:

  • summary of product characteristics (annex I);
  • manufacturing authorisation holder responsible for batch release (annex IIA);
  • conditions of the marketing authorisation (annex IIB);
  • labelling (annex IIIA);
  • package leaflet (annex IIIB).

You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.

Pharmacotherapeutic group

Live viral vaccines

Therapeutic indication

For the active immunisation of red foxes and raccoon dogs to prevent infection by rabies virus.
The duration of protection is of at least 6 months.

Assessment history

How useful was this page?

Add your rating